FY2026 · ended Jun 30, 2026 · Revenue $401.95M, -12.3% YoY · Filed Aug 27, 2026
Accuray Inc (ARAY) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2026, which ended Jun 30, 2026, it reported revenue of $401.9 million and a net loss of $49.2 million. Free cash flow was -$12.8 million. As of Jun 30, 2026 it held $40.6 million in cash and investments and $183.9 million in total debt.
Revenue
$401.95M
-12.3% vs prior year
Net income
$-49.19M
-2992.0% vs prior year
Operating cash flow
$-6.98M
-344.1% vs prior year
Free cash flow
$-12.84M
-809.5% vs prior year
EPS
$-0.02
+87.5% vs prior year
Dividend per share
None
Shares outstanding
119.44M
+0.6% vs prior year
Net cash
$-143.25M
FY 2026
Operating margin
-6.6%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ARAY (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Madison, WI
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1138723
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Jun 30, 2026 |
FY 2025 Jun 30, 2025 |
FY 2024 Jun 30, 2024 |
FY 2023 Jun 30, 2023 |
FY 2022 Jun 30, 2022 |
|---|---|---|---|---|---|
| Revenue | $401.9M | $458.5M | $446.6M | $447.6M | $429.9M |
| Operating income | -$26.4M | $7.8M | $504,000 | $2.4M | $8.1M |
| Net income | -$49.2M | -$1.6M | -$15.5M | -$9.3M | -$5.3M |
| Diluted EPS | — | -$0.02 | -$0.16 | -$0.10 | -$0.06 |
| Operating cash flow | -$7.0M | $2.9M | -$11.9M | $15.5M | -$2.4M |
| Free cash flow | -$12.8M | -$1.4M | -$15.5M | $2.9M | -$7.1M |
| Total assets | $443.7M | $470.2M | $468.6M | $479.2M | $472.8M |
| Total liabilities | $402.0M | $389.1M | $423.5M | $425.6M | $419.7M |
| Stockholders' equity | $41.7M | $81.2M | $45.1M | $53.7M | $53.2M |
| Cash and investments | $40.6M | $57.4M | $68.6M | $89.4M | $88.7M |
| Total debt | $183.9M | $189.1M | $218.5M | $210.8M | $208.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| ARS | Annual report to shareholders | Oct 16, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 13, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Oct 6, 2026 | Oct 5, 2026 |
| 10-K | Annual report | Aug 27, 2026 | Jun 30, 2026 |
All 1002 Accuray Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.